‘Chemical Ali’ Death Sentence Confirmed
The remaining days of Ali Hassan al-Majid, aka "Chemical Ali," are numbered. More specifically, after an Iraqi court upheld his June sentence, al-Majid, who earned his nickname by playing a key role in the gassing deaths of some 100,000 Kurds in 1988, has 30 days or less to live.
The remaining days of Ali Hassan al-Majid, aka “Chemical Ali,” are numbered. More specifically, after an Iraqi court upheld his June sentence, al-Majid, who earned his nickname by playing a key role in the gassing deaths of some 100,000 Kurds in 1988, has 30 days or less to live.
Your support matters…BBC:
Majid is currently also on trial for the brutal suppression of a Shia uprising in southern Iraq after the first Gulf War in 1991.
The BBC’s Andrew North in Baghdad says it is likely he will now be executed before that trial can be completed, because the government has to carry out the death sentence within 30 days.
Independent journalism is under threat and overshadowed by heavily funded mainstream media.
You can help level the playing field. Become a member.
Your tax-deductible contribution keeps us digging beneath the headlines to give you thought-provoking, investigative reporting and analysis that unearths what's really happening- without compromise.
Give today to support our courageous, independent journalists.
Disgraced movie mogul faces new charges of assaulting two women during Oscar week in 2013 as jury selection is set to begin in Manhattan.
The American, British and Swedish judicial systems have been manipulated and corrupted to ensure the publisher is extradited to the U.S.
Court statements veered from the scientist's original conclusions in at least three cases.
Current and former employees of the fast-food chain have joined a class-action lawsuit claiming they had to work extra hours without pay.
On Wednesday, Richard Glossip will face execution by the state of Oklahoma despite mounting evidence pointing to his innocence.
You need to be a supporter to comment.
There are currently no responses to this article.
Be the first to respond.